Maurizio Anzini

Prof. Maurizio Anzini

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMaurizio Anzini
Maurizio Anzini
ACAlessia Chelini
Alessia Chelini
AMAlessandra Mancini
Alessandra Mancini
ACAndrea Cappelli
Andrea Cappelli
Maria FrosiniMaria Frosini
Maria Frosini
SVSalvatore Vomero
Salvatore Vomero


4 July 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMaurizio Anzini
Maurizio Anzini
MRMichele Rovini
Michele Rovini
ACAndrea Cappelli
Andrea Cappelli
SVSalvatore Vomero
Salvatore Vomero
Fabrizio ManettiFabrizio Manetti
Fabrizio Manetti
Mariangela BiavaMariangela Biava
Mariangela Biava

11 April 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMaurizio Anzini
Maurizio Anzini
ACAngela Di Capua
Angela Di Capua
SVSalvatore Valenti
Salvatore Valenti
Simone BrogiSimone Brogi
Simone Brogi
MRMichele Rovini
Michele Rovini
Mariangela BiavaMariangela Biava
Mariangela Biava

27 July 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMaurizio Anzini
Maurizio Anzini
SVSalvatore Valenti
Salvatore Valenti
CBCarlo Braile
Carlo Braile
ACAndrea Cappelli
Andrea Cappelli
SVSalvatore Vomero
Salvatore Vomero
GBGiovanni Biggio
Giovanni Biggio

1 January 2010 in Molecular Pain
Verified
Journal Article
Open access
AAAnna Maria Aloisi
Anna Maria Aloisi
ICIlaria Ceccarelli
Ilaria Ceccarelli
PFPaolo Fiorenzani
Paolo Fiorenzani
MMMelinda Maddalena
Melinda Maddalena
ARAlessandra Rossi
Alessandra Rossi
Antonio GiordanoAntonio Giordano
Antonio Giordano
Background: The steroid hormone testosterone has been found to be greatly reduced by opioids in different experimental and clinical conditions. The purpose of this study on male rats was to determine the effects of a single injection of morphine (5 mg/Kg) on persistent pain (formalin test) and the single or combined effects on p450-aromatase and 5-alpha reductase type 1 mRNA expression in the brain, liver and testis. Testosterone was determined in the plasma and in the brain, morphine was assayed in the plasma. Results: In the morphine-treated rats, there were increases of 5-alpha reductase mRNA expression in the liver and aromatase mRNA expression in the brain and gonads. Morphine was detected in the blood of all morphine-treated rats even though there were no clear analgesic affects in the formalin-treated animals three hours after treatment. Testosterone was greatly reduced in the plasma and brain in morphine-treated subjects. Conclusions: It appears that morphine administration can induce long-lasting genomic effects in different body areas which contribute to the strong central and peripheral testosterone levels. These changes were not always accompanied by behavioral modifications.